Detalles de la búsqueda
1.
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.
Oncology
; 101(11): 723-729, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379817
2.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37133230
3.
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer.
Int J Gynecol Cancer
; 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37945055
4.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma
; 70(1): 158-165, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620878
5.
Gemcitabine-associated DRESS syndrome: A case report.
J Oncol Pharm Pract
; 29(6): 1480-1483, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006201
6.
Vinorelbine-related tetraplegia due to severe peripheral neuropathy.
J Oncol Pharm Pract
; : 10781552231191469, 2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37499222
7.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581821
8.
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Cancer Invest
; 40(2): 199-209, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894960
9.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35703239
10.
Sarcoma - correlation between CD73 and PD-L1 and their relationship with prognosis.
Pol J Pathol
; 73(4): 338-342, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946270
11.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326360
12.
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Cancer Invest
; 39(6-7): 473-481, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014777
13.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023933
14.
Prognostic and predictive value of EZH2 expression and the tumor immune microenvironment in Merkel cell carcinoma.
Pol J Pathol
; 72(2): 140-147, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706521
15.
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
Oncologist
; 25(1): e39-e47, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31604903
16.
Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.
Ann Hematol
; 99(2): 301-307, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844933
17.
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Ann Hematol
; 99(11): 2565-2576, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507911
18.
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Eur J Cancer Care (Engl)
; 29(6): e13296, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864838
19.
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
J Cancer Educ
; 35(1): 69-75, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446981
20.
Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma.
Ann Hematol
; 98(7): 1803, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31161385